Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Minutes, not days: new rapid test could speed up thyroid cancer detection

NCT ID NCT05078853

Diagnosis Sponsor: Soroka University Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new rapid test that checks for thyroid cancer spread to neck lymph nodes in just minutes, instead of the usual days-long wait. Researchers studied 250 adults with suspected or known thyroid cancer, comparing the quick test to standard lab methods. The goal was to see if the rapid test is accurate enough to help doctors make faster treatment decisions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

250 people

The number who actually took part.

Started

Oct 2021

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

FNA Clinic: Patients evaluated in FNA clinic for cervical lymph node/s suspected as DTC metastasis. Operating room: Patients operated for known or suspected DTC with cervical lymph node/s metastasis.

Ages

18 to 120 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients who are able and agree to sign the informed consent document. 2. Aged 18 years or older. In the FNA clinic arm: 3. Patients evaluated for thyroid nodule/s suspected or known as DTC, accompanied by cervical LN/s suspected as DTC metastasis. 4. Patients following treatment for DTC (partial or total thyroidectomy, with or without compartmental neck dissection), with cervical LN/s suspected as DTC recurrency. In the OR arm: 5. Patients operated for known DTC (partial or total thyroidectomy, with or without compartmental neck dissection). 6. Patients operated for DTC recurrency ('completion' and/or compartmental neck dissection). \- Exclusion Criteria: Pregnant women \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Differentiated thyroid cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

differentiated thyroid carcinoma Lymphatic Metastasis metastatic malignant neoplasm in the lymph nodes Thyroid Cancer, Papillary

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Differentiated thyroid cancer Lymph node metastases

Contacts and locations

Locations

  • A.R.M Medical Center, Assuta Ramat Hahayal

    Tel Aviv, 69710, Israel

  • Barzilai Medical Center

    Ashkelon, Israel

  • Hebrew University Medical Center, Mount Scopus

    Jerusalem, Israel

  • Sheba Medical Center

    Ramat Gan, 52621, Israel

  • Soroka University Medical Center

    Beersheba, 84101, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.